Cleveland Clinic's labor costs jumped 16.6% while inpatient admissions dropped 2.3%.

A combination of lost Medicaid reimbursements, expiring policy flexibilities and a funding cliff worry community health center leaders.

The lawmakers want to preserve telehealth flexibilities created during the COVID-19 pandemic, focusing on Medicare, Medicaid and schools.

A policy that could erase thousands of regulations would have caused more harm than good, according to the Biden administration.

An aging population in need of regular cancer screenings has driven private equity companies, seeking profits, to invest in many gastroenterology practices and set up aggressive billing practices.

Starting in 2023, Aetna and CVS Caremark members will be able to access remote care teams, virtual care services and their own interoperable electronic health record.

Health systems are researching the implications of lingering health problems among COVID-19 survivors.

More than 1,300 unionized residents and other trainees at three L.A. County public hospitals will vote May 30 on whether to strike for a bump in their salaries and housing stipends, after a monthslong negotiation deadlock with the county.

New concepts focus on personalization and patient experience.

Small children are showing up ill at hospitals because of the formula shortage. After they're treated, they often have to come back.

Most physicians saw income return to pre-pandemic levels last year, the Medical Group Management Association reports.

CEO Randy Oostra had also served as president of the Toledo, Ohio-based not-for-profit system.

Antonio Ciaccia, CEO of drug pricing research firm 46brooklyn Research and president of 3 Axis Advisors, discusses what’s driving payer lawsuits against pharmacy benefit managers, and the role these middlemen play in determining drug prices.

The coronavirus mutant that is now dominant in the U.S. is a member of the omicron family but scientists say it spreads faster than its omicron predecessors.

Conflict often stems from unmet expectations, and let’s face it, we have a lot of those in healthcare right now.

Although the U.S. commitment eventually expanded to $1.8 billion, hardly any Novavax shots have found arms due to manufacturing issues, and most of the world has moved on.

The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island, providing patients with immediate access to the drug once they test positive. More federally supported sites are set to open in the coming weeks.

The health industry reports the surprise billing ban is protecting patients, but providers believe it's at their expense.

Physicians say insurers aren't complying with an agreement to ease prior authorizations, according to a survey.